Agilent Technologies has announced it really is acquiring the developing in Boulder where they have already been producing therapeutic oligonucleotides (“oligos") for more than a decade. This $12 million buy, alo…Find out more Period I trials: Researchers exam a drug or treatment in a little team of folks (20–eighty) for http://clinicalresearchdenver04677.xzblogs.com/18672912/the-best-side-of-stem-cell-diabetes-treatment